BackArtiva Biotherapeutics Overview

Artiva Biotherapeutics Accounts Payable

Track Artiva Biotherapeutics's accounts payable ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer average / median

Loading

Artiva Biotherapeutics Accounts Payable History

Loading

Artiva Biotherapeutics vs. peers: Accounts Payable Comparison

Loading

Artiva Biotherapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Artiva Biotherapeutics (ARTV) FAQ

As of the most recent data (June 2026), ARTV shows a accounts payable of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ARTV's accounts payable is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Artiva Biotherapeutics is outperforming or lagging.

Tracking ARTV's accounts payable over time shows whether Artiva Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Artiva Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.